Immunomic Therapeutics Incorporated (ITI), located in Rockville, Maryland recently announced it had closed on $61.3M in financing, exceeding its initial fundraising projections by over $11M. The Korean investment group HLB Co., LTD led the financing round, which is just the latest accomplishment for the clinical-stage biotechnology company that launched in 2006.
{iframe}https://biobuzz.io/marylands-immunomic-therapeutics-exceeds-fundraising-goal-envisions-future-ipo/{/iframe}